Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Canadian Prevention of Renal and Cardiovascular Endpoints Trial

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2005 by Memorial University of Newfoundland.
Recruitment status was:  Recruiting
Sponsor:
Collaborators:
Canadian Institutes of Health Research (CIHR)
Canadian Diabetes Association
The Kidney Foundation of Canada
Heart and Stroke Foundation of Canada
Merck Frosst Canada Ltd.
Amgen
Janssen-Ortho Inc., Canada
Information provided by:
Memorial University of Newfoundland
ClinicalTrials.gov Identifier:
NCT00231803
First received: September 30, 2005
Last updated: October 6, 2005
Last verified: October 2005